Annual report pursuant to Section 13 and 15(d)

Accrued Liabilities (Tables)

v3.8.0.1
Accrued Liabilities (Tables)
12 Months Ended
Dec. 31, 2017
Accrued Liabilities and Other Liabilities [Abstract]  
Schedule of Accrued Liabilities
Accrued liabilities consisted of the following:
 
 
 
December 31,
 
 
 
2017
 
2016
 
Salaries, benefits and related expenses
 
$
2,850
 
$
2,303
 
Device maintenance
 
 
121
 
 
483
 
Device warranty
 
 
232
 
 
203
 
Clinical trials
 
 
136
 
 
35
 
Capital lease obligation
 
 
34
 
 
54
 
Other
 
 
130
 
 
52
 
Total
 
$
3,503
 
$
3,130
 
Reconciliation of Changes in Maintenance and Warranty Liabilities
In addition, in the year ended December 31, 2016, the Company recorded in its consolidated statements of operations and comprehensive loss a one-time charge of $911 for a preventative maintenance and improvement program for devices sold prior to 2016 to bring the devices to second generation GT-level functionality. In the year ended December 31, 2017, the Company reassessed the number of devices still needing to be brought to second generation GT-level functionality and adjusted the maintenance accrual accordingly.
 
 
 
2017
 
 
 
Maintenance
 
Warranty
 
Total
 
Balance at December 31, 2016
 
$
483
 
$
204
 
$
687
 
Additions for estimated future expense
 
 
-
 
 
207
 
 
207
 
Incurred costs
 
 
(229)
 
 
(179)
 
 
(408)
 
Adjustment from remeasurement
 
 
(133)
 
 
 
 
 
(133)
 
Balance at December 31, 2017
 
$
121
 
$
232
 
$
353
 
 
 
 
 
 
 
 
 
 
 
 
Current portion
 
 
121
 
 
232
 
 
353
 
Long-term portion
 
 
-
 
 
-
 
 
-
 
Total
 
$
121
 
$
232
 
$
353
 
 
 
 
2016
 
 
 
Maintenance
 
Warranty
 
Total
 
Balance at December 31, 2015
 
$
-
 
$
-
 
$
-
 
Additions for estimated future expense
 
 
911
 
 
430
 
 
1,341
 
Incurred costs
 
 
(428)
 
 
(226)
 
 
(654)
 
Balance at December 31, 2016
 
$
483
 
$
204
 
$
687
 
 
 
 
 
 
 
 
 
 
 
 
Current portion
 
 
483
 
 
203
 
 
686
 
Long-term portion
 
 
-
 
 
1
 
 
1
 
Total
 
$
483
 
$
204
 
$
687